Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1152-1158

  Mornex, Françoise ^a   Girard, Nicolas ^a   Beziat, Christophe ^b   Kubas, Abdul ^a   Khodri, Mustapha ^a   Trepo, Christian ^b   Merle, Philippe ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cirrhosis; Conformal radiotherapy; Hepatocellular carcinoma

Indexed keywords

DISEASES; OPTIMIZATION; PATIENT TREATMENT; TUMORS;

CIRRHOSIS; CONFORMAL RADIOTHERAPY; HEPATOCELLULAR CARCINOMA;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT;

EID: 33750969661     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.06.015     Document Type: Article

References (40)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
3. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217 (1993) 375-384
4. Decadt B., and Sirlwardena A. Radiofrequency ablation of liver tumors: Systematic review. Lancet Oncol 5 (2004) 550-560
5. Kotoh K., Sakai H., Sakamoto S., et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 89 (1994) 194-198
6. Groupe d'Étude et de Traitement du Carcinome Hépatocellulaire. Comparison of lipidol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
7. Cancer of the Liver Italian Programme (CLIP) Group. Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial. Lancet 352 (1998) 17-20
8. Stillwagon G.B., Order S.E., Guse C., et al., A radiation therapy oncology group study. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: Toxicity and response. I J Radiat Oncol Biol Phys 17 (1989) 1223-1229
9. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
10. Lawrence T.S., Tesser R.J., and ten Haken R.K. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 19 (1990) 1041-1047
11. Dawson L.A., Brock K.K., Kazanjian S., et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 1410-1421
12. Robertson J.M., Lawrence T.S., Dworzanin L.M., et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 11 (1993) 1286-1293
13. Cheng S.H., Lin Y.M., Chuang V.P., et al. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 1025-1033
14. Mornex F., Girard N., Merle P., et al. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients Results of the French RTF 1 phase II trial]. Cancer Radiother 9 (2005) 470-476
15. Ten Haken R.K., Lawrence T.S., McShan D.L., et al. Technical considerations in the use of 3-D beam arrangements in the abdomen. Radiother Oncol 22 (1991) 19-28
16. Rosu M., Dawson L.A., Balter J.M., et al. Alterations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys 57 (2003) 1472-1479
17. Robertson J.M., McGinn C.J., Walker S., et al. A Phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys 39 (1997) 1087-1092
18. McGinn C.J., Ten Haken R.K., Ensminger W.D., et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16 (1998) 2246-2252
19. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
20. Karnofsky D.A., and Buchenal J.H. The clinical evaluation of chemotherapeutic agents. In: MacLeod C.M. (Ed). Evaluation of chemotherapeutic agents (1949), Columbia University Press, New York 191-205
21. Child C.G., and Turcotte J.G. Surgery and portal hypertension. In: CG (Ed). The Liver and Portal Hypertension (1964), W.B. Saunders, Philadelphia 50-64
22. World Health Organisation. WHO handbook for reporting results of cancer treatment. World Health Organization Offset Publication, No. 48, 1979. Geneva, Switzerland.
23. Bruix J., Sherman M., Llovet J.M., et al., Clinical management of hepatocellular carcinoma, European Association for the study of the Liver. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 (2001) 421-430
24. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
25. Late Effects of Normal Tissues (LENT) Consensus Conference. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091
26. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
27. Robertson J.M., Lawrence T.S., Andrews J.C., et al. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys 37 (1997) 325-330
28. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
29. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
30. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Sem Radiat Oncol 15 (2005) 279-283
31. Lawrence T.S., Dworzanin L.M., Walker-Andrews S.C., et al. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys 20 (1991) 555-561
32. Liu M.T., Li S.H., Chu T.C., et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34 (2004) 532-539
33. Park H.C., Seong J., Han K.H., et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
34. Lin S.M., Lin C.J., Lin C.C., et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127 (2004) 1714-1723
35. Cheng J.C., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 54 (2002) 156-162
36. Cheng J.C., Wu J.K., Huang C.M., et al. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 56 (2003) 229-234
37. Cheng J.C., Wu J.K., Lee P.C., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60 (2004) 1502-1509
38. Fuss M., Salter B.J., Cavanaugh S.X., et al. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 59 (2004) 1245-1256
39. Yamada K., Izaki K., Sugimoto K., et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57 (2003) 113-119
40. Hashimoto T., Tokuuye K., Fukumitsu N., et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 196-202